Word

LIVING HYPOPARA

Status

Pending

Status Code

661

Status Date

Friday, September 27, 2024

Serial Number

98041740

Mark Type

3

Filing Date

Wednesday, June 14, 2023

Trademark Owner History

Ascendis Pharma Endocrinology Division A-S

Classifications

41 Educational and teaching services, namely, providing conferences, symposiums, seminars, workshops, lectures, classes and online education seminars in the field of pharmaceuticals, medicine, and health care; Publication of non-downloadable electronic publications in the nature of ad boards, magazines, journals and articles in the field of pharmaceutical, medical and healthcare topics; Editorial reporting services; News syndication reporting; Educational services, namely, conducting educational programs for patients and healthcare providers related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders

9 Downloadable computer software and downloadable computer application software for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders

44 Providing and sharing of medical information and advice relating to growth hormone deficiency, endocrinological disorders, and bone and skeletal disorders, diagnosis and treatment, medical screening, medicine, health and pharmaceutical products; Patient support program, namely, providing health care information to patients and healthcare providers in the field of growth hormone deficiency, endocrine disorders, and bone and skeletal disorders diagnosis and treatment including providing information on self-administering medications; Providing an online website featuring medical and healthcare information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders

The mark consists of the wording "LIVING HYPOPARA" in blue text with the word "LIVING" inside a yellow shaded circle.
LIVING HYPO PARA
The color(s) yellow and blue is/are claimed as a feature of the mark.
HYPOPARA

Trademark Events

Jun 17, 2023

New Application Entered

Jul 18, 2023

New Application Office Supplied Data Entered

Jul 19, 2023

Notice Of Design Search Code E-Mailed

Feb 14, 2024

Assigned To Examiner

May 17, 2024

Teas Response To Office Action Received

Feb 21, 2024

Non-Final Action Written

Feb 21, 2024

Non-Final Action E-Mailed

Feb 21, 2024

Notification Of Non-Final Action E-Mailed

May 17, 2024

Correspondence Received In Law Office

May 17, 2024

Teas/Email Correspondence Entered

May 29, 2024

Letter Of Suspension E-Mailed

May 29, 2024

Suspension Letter Written

Sep 26, 2024

Assigned To Lie

Sep 27, 2024

Correspondence Received In Law Office

Sep 27, 2024

Teas/Email Correspondence Entered

May 30, 2024

Teas Response To Suspension Inquiry Received

May 29, 2024

Notification Of Letter Of Suspension E-Mailed